Enhancing Cardiovascular Risk Prediction with a Simplified Carotid IMT Protocol: Evidence from the IMPROVE Study
- PMID: 40149561
- PMCID: PMC11940431
- DOI: 10.3390/biomedicines13030584
Enhancing Cardiovascular Risk Prediction with a Simplified Carotid IMT Protocol: Evidence from the IMPROVE Study
Abstract
Background/Objectives: Carotid intima-media thickness (CIMT) has long been used as an index of subclinical atherosclerosis, but its role as a risk modifier in cardiovascular (CV) risk optimization has recently been questioned due to methodological problems, such as lack of protocol standardization and scanning difficulties. In this multicentre, longitudinal, and observational study, we tested the predictive ability of two new CIMT variables detectable with a simplified, quick, and easy-to-standardize protocol. Methods: CIMT was measured in 3165 subjects from six centers, in five European countries, belonging to the IMPROVE study. The two variables tested were the average of two maximal CIMT measures taken, from a single angle, in the right and left common carotids (1CC-IMTmean-of-2-max) or bifurcations (BIF-IMTmean-of-2-max). The ability to predict CV events, on top of the SCORE2/SCORE2-OP risk algorithm, was quantified by the time-dependent increase in the receiver operating characteristic (ROC) area under the curve (AUC). Results: During a median follow-up of 7.1 years, 367 cardio-, cerebro-, and peripheral-vascular events were registered. Both CIMT variables tested were associated with CV risk, but 1CC-IMTmean-of-2-max was also able to significantly increase the ROC AUC over the risk score (+0.017, p = 0.014). The result was stable after running several sensitivity analyses. Conclusions: 1CC-IMTmean-of-2-max is able to significantly improve the predictive capacity of SCORE2/SCORE2-OP. Being based on a simple and easily standardized measurement protocol, this new variable is a promising candidate for application in mass screening and risk assessment in primary prevention.
Keywords: IMPROVE study; carotid artery; intima-media thickness; plaque; ultrasonography protocol.
Conflict of interest statement
The authors declare that this study received funding from the European Commission, Fifth Framework Programme (Contract number: QLG1-CT-2002-00896; to E.T., D.B.) and by the Ministry of Health, Italy (RC. 2771964-4.10, to D.B.; RF-2018-12366565, to E.T., D.B.). R.J.S. was supported by UKRI Innovation-HDR-UK (MR/S003061/1) and the University of Glasgow Lord Kelvin Adam Smith Fellowships. A.G. has received some grants or contracts from Amryt and Sanofi; consulting fees from Amgen, Sanofi, Novartis, Ultragenyx and Amryt; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Amgen, Astrazeneca, Sanofi, Novartis, Organon, Amarin Corporation, Ultragenyx and Servier; and support for attending meetings and/or travel from Sanofi, Organon and Ultragenyx. A.M.M., M.A., B.F., R.B., D.C., N.C., D.S., A.R., K.S., P.G., M.P., B.G., P.E., D.J.M. and F.V. declare no conflicts of interest. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Howard G., Burke G.L., Evans G.W., Crouse J.R., 3rd, Riley W., Arnett D., de Lacy R., Heiss G. Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Atherosclerosis Risk in Communities. Stroke. 1994;25:1581–1587. doi: 10.1161/01.STR.25.8.1581. - DOI - PubMed
 
LinkOut - more resources
- Full Text Sources
- Miscellaneous
 
        